MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Report search

Report search

Perform another search

Search results for: AstraZeneca
Within categories: Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology, Healthcare,
Search results Pages: 1 2 3 4 5 6 7 8 9 10 11 12
Found: 301 documents.

Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
Published by: Datamonitor - 8/6/2009 - (340  Pages)
View table of contents

Description
Introduction

Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new te...(more)

Purchase Options

The Global Influenza Market
Published by: BCC Research - 8/1/2009 - (162  Pages)
View table of contents

Description
THIS REPORT:

Provides a thorough evaluation of the market for influenza vaccines, therapeutics, and diagnostics

Offers a global analysis, with emphasis on U.S. data, and a fiv...(more)

Purchase Options

Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
Published by: CurrentPartnering - 2/1/2009 - (365  Pages)
View table of contents

Description
The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either ...(more)

Purchase Options

Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition
Published by: CurrentPartnering - 2/1/2009 - (377  Pages)
View table of contents

Description
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered int...(more)

Purchase Options

Peru Pharmaceuticals and Healthcare Report Q1 2009
Published by: Business Monitor International - 1/30/2009 - (65  Pages)
View table of contents

Description
In BMI’s updated Business Environment Rankings (BER) for Q109, Peru has slipped from second-last tolast position in the Americas matrix, thus remaining one of the least attractive pharmaceutical...(more)

Purchase Options

Managed Markets Account Management: Assessing the Performance of Account Executives
Published by: Best Practices, LLC - 10/1/2009 - (52  Pages)
View table of contents

Description
STUDY OVERVIEW

Today's market driven environment has made performance assessment of managed market account executives complex and critical. Best Practices, LLC has conducted this in-depth stud...(more)

Purchase Options

Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics
Published by: CurrentPartnering - 7/1/2009 - (589  Pages)
View table of contents

Description
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements ...(more)

Purchase Options

The Pricing and Reimbursement Environment for Immune Disease Therapies
Published by: Decision Resources - 6/25/2009 - (45  Pages)
View table of contents

Description
Introduction

Drug therapies for immune disorders span an enormous price range—from a few cents per day to tens of thousands of dollars per year. Not surprisingly, payers impose restricti...(more)

Purchase Options

Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
Published by: CurrentPartnering - 6/1/2009 - (471  Pages)
View table of contents

Description
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the wor...(more)

Purchase Options

The Elder Care Market: Products and Services
Published by: BCC Research - 6/1/2009 - (213  Pages)
View table of contents

Description
REPORT HIGHTLIGHTS

  • The U.S. eldercare market was worth $279.2 billion in 2008 and an estimated $316.9 billion in 2009. This should reach $447.4 billion in 2014, for a compound annual growth ...(more)

    Purchase Options

    Cancer Therapies
    Published by: Global Industry Analysts - 2/1/2009 - (694  Pages)
    View table of contents

    Description
    This report analyzes the global market for Cancer Therapies in US$ Billion. The specific product segments analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forec...(more)

    Purchase Options

    Worldwide Nanotechnology Dental Implant Market Shares, Strategies, and Forecasts, 2009 to 2015
    Published by: Wintergreen Research - 4/19/2009 - (335  Pages)
    View table of contents

    Description
    WinterGreen Research announces that it has a new study on Worldwide nanotechnology dental implant markets. Worldwide dental implants are poised to achieve significant growth as patients become aware o...(more)

    Purchase Options

    The Chinese Hospital Pharmaceutical Market Outlook To 2014: Policy environment, healthcare system, market structure, competitive landscape, growth opportunities
    Published by: Business Insights - 6/1/2009 - (127  Pages)
    View table of contents

    Description
    The Chinese Hospital Pharmaceutical Market Outlook to 2014’ provides comprehensive coverage of the Chinese pharmaceutical market, reviewing the market structure, pricing and regulation, and incl...(more)

    Purchase Options

    Pharmacovigilance Report and Analysis 2009: Present Challenges and Future Goals
    Published by: Visiongain - 4/21/2009 - (136  Pages)
    View table of contents

    Description
    Pharmacovigilance has been expanding in recent years, as companies are required to monitor drug safety post launch. Drug safety issues, such as those raised by Vioxx earlier this decade, have led to i...(more)

    Purchase Options

    China Pharmaceuticals and Healthcare Report Q4 2009
    Published by: Business Monitor International - 10/15/2009 - (105  Pages)
    View table of contents

    Description
    In BMI’s view, China is arguably the most attractive emerging pharmaceutical market. Though to 2013,we are forecasting a compound annual growth rate (CAGR) of 15.45%. Annual per-capita spending ...(more)

    Purchase Options

    Protein Kinase Therapeutics in Oncology - Where to Commercialize?
    Published by: BioSeeker Group AB - 10/29/2009 - (1,442  Pages)
    View table of contents

    Description

    This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extens...(more)

    Purchase Options

    Forecast Insight: Top 20 Cancer Therapy Brands Targeted therapies will drive market growth in the wake of the cytotoxic and antihormonal patent cliff
    Published by: Datamonitor - 9/22/2009 - (108  Pages)
    View table of contents

    Description
    Introduction

    The cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer ...(more)

    Purchase Options

    Ion Channel Modulator Pipelines: Targets and Agents in Development
    Published by: CHI Insight Pharma Reports - 9/1/2009 - (154  Pages)
    View table of contents

    Description

    Ion channels represent a significant opportunity to address an underexploited class of therapeutic targets. Nearly 150 novel ion channel modulators are reported to be in clinical development. This ...(more)

    Purchase Options

    The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
    Published by: Kalorama Information - 5/1/2009 - (280  Pages)
    View table of contents

    Description
    Worldwide cancer affects more than 10 million people each year. This number is expected to increase by 2.4% by 2020 to 14 million each year. Worldwide approximately 22 million people are living with...(more)

    Purchase Options

    Therapeutics for Memory and Cognition Disorders
    Published by: BCC Research - 4/1/2009 - (165  Pages)
    View table of contents

    Description
    Details the disease states that lead to memory & cognition impairment
    Provides forecasts and detail relative to the products available to treat this condition.

    Provides definition and ma...(more)

    Purchase Options

    Global Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
    Published by: Global Markets Direct - 3/17/2009 - (237  Pages)
    View table of contents

    Description
    Global Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

    Summary

    This Medical Device report is an essential source for key information and data relati...(more)

    Purchase Options

    MarketWatch: Health Round-up
    Published by: Datamonitor - 2/17/2009 - (31  Pages)
    View table of contents

    Description
    Datamonitor's MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the lates...(more)

    Purchase Options

    Poland Pharmaceuticals and Healthcare Report Q1 2009
    Published by: Business Monitor International - 2/6/2009 - (69  Pages)
    View table of contents

    Description
    Poland’s pharmaceutical market remains heavily pro-generic, meaning opportunities for innovative drugmakers are limited. Nevertheless, the sheer size of the overall pharmaceutical market - which...(more)

    Purchase Options

    United Kingdom Pharmaceuticals and Healthcare Report Q1 2009
    Published by: Business Monitor International - 1/30/2009 - (107  Pages)
    View table of contents

    Description
    In BMI.s new Business Environment Rankings for Q109, the UK continued to slip down the WesternEuropean table, and now occupies a lowly sixth position. Indeed, on a global scale the UK is nowpositioned...(more)

    Purchase Options

    United Kingdom Pharmaceuticals and Healthcare Report Q4 2009
    Published by: Business Monitor International - 10/8/2009 - (97  Pages)
    View table of contents

    Description
    In BMI’s Business Environment Ratings (BER) for Q409, the UK improved its position by one place,and is now ranked 5th of the 9 Western European markets surveyed. However, while the UK is one of ...(more)

    Purchase Options

    Peru Pharmaceuticals and Healthcare Report Q4 2009
    Published by: Business Monitor International - 10/8/2009 - (73  Pages)
    View table of contents

    Description
    BMI calculates that pharmaceutical sales in Peru reached PEN2.58bn (US$0.88bn) in 2008. Thisrepresents impressive growth of 8.5% in local currency terms between 2007 and 2008. However, BMI’sfore...(more)

    Purchase Options

    Pages: 1 2 3 4 5 6 7 8 9 10 11 12

    Perform another search

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us